OrbiMed portfolio
177 tracked investments, 137 on the map, $9.6B raised across the mapped portfolio.
OrbiMed177 investments · 137 on the map · $9.6B raised- Intellia Therapeutics
- Harmony BiosciencesDebt Financing
- Janux TherapeuticsSeries B
- Arcutis Biotherapeutics
- Mineralys TherapeuticsPost-IPO Equity
- InvivydSeries C
- Avalo TherapeuticsPost-IPO Equity
- Aspen NeuroscienceSeries C
- Keros TherapeuticsSeries C
- Alentis Therapeutics
- DELFI Diagnostics
- Mirador Therapeutics
- Cerapedics
- Trisalus Life SciencesPost-IPO Debt
- Cytek BiosciencesSeries D
- Noctrix Health
- AdimabSeries D
- Koya MedicalSeries C
- Verastem OncologyPost-IPO Equity
- SynthorxSeries C
- LEXICON PHARMACEUTICALSPost-IPO Equity
- NeuroPaceVenture
- Targanta TherapeuticsSeries C
- enGenePost-IPO Equity
- Owlet Baby CarePost-IPO Equity
- Perfuse TherapeuticsSeries A
- Sidewinder TherapeuticsSeries B
- Terremoto BiosciencesSeries C
- BlossomHill TherapeuticsSeries B
- Terns PharmaceuticalsSeries C
- Avenzo TherapeuticsSeries B
- RayzeBioSeries C
- vVardisVenture Round
- BiobeatSeries B
- Fore BiotherapeuticsSeries D
- SpectronRxPrivate Equity Round
- Compass TherapeuticsPost-IPO Equity
- Q32 BioPost-IPO Equity
- MinervaxVenture Round
- KapivaSeries C
- ReCode TherapeuticsSeries B
- argenxSeries B
- ApollomicsSeries B
- Pee SafeSeries C
- Repare TherapeuticsSeries B
- Zai LabSeries C
- Edgewise TherapeuticsPost-IPO Equity
- Leal TherapeuticsSeries A
- InsmedPost-IPO Debt
- ProLynxSeries A
- Stratus TherapeuticsSeries A
- Binx HealthSeries E
- QuantX BiosciencesSeries A
- Myriad GeneticsPost-IPO Debt
- Congruence TherapeuticsVenture Round
- Sionna TherapeuticsSeries C
- Ascendis PharmaSeries D
- Iovance BiotherapeuticsPost-IPO Equity
- Avita MedicalPost-IPO Debt
- ETHRISSeries A
- AdelaSeries A
- Helicore BiopharmaSeries A
- Alpheus MedicalSeries B
- Vanqua BioSeries B
- YarrowVenture Round
- ValnevaPost-IPO Debt
- ACELYRINSeries C
- EmendoBio, Inc.Series B
- C4 TherapeuticsPost-IPO Equity
- sikka.aiSeries C
- LifeCell InternationalVenture Round
- Pionyr ImmunotherapeuticsSeries B
- Fate TherapeuticsPost-IPO Equity
- Adaptive BiotechnologiesPost-IPO Debt
- NetmedsSeries A
- Scout BioSeries B
- Pinnacle MedicinesSeries A
- InvitaeSeries F
- Theseus PharmaceuticalsSeries B
- ImmPACT BioSeries B
- DIH TechnologyPost-IPO Equity
- Cullinan TherapeuticsPost-IPO Equity
- Promentis PharmaceuticalsSeries C
- MabPlex InternationalSeries B
- Suraksha DiagnosticsVenture Round
- 89bioSeries A
- BIOMxPost-IPO Equity
- VIVUSPost-IPO Equity
- Cyrus BiotechnologySeries B
- Passage BioSeries B
- Harvest Integrated Research OrganizationSeries A
- RedHill BiopharmaPost-IPO Equity
- Fusion PharmaceuticalsSeries B
- Corvus PharmaceuticalsPost-IPO Equity
- Kerala Institute of Medical SciencesPrivate Equity Round
- Alpine Immune SciencesPost-IPO Equity
- AvitideSeries E
- Arcatron MobilityVenture Round
- TELA BioVenture Round
- Sublimity TherapeuticsVenture Round
- Sierra OncologySeries D
- scPharmaceuticalsSeries B
- MobileODTSeries C
- ViewRayPost-IPO Equity
- Corteria PharmaceuticalsSeries A
- TricidaPost-IPO Equity
- Aeglea BioTherapeuticsSeries B
- Chinook TherapeuticsPost-IPO Equity
- AttenuaSeries A
- Pandion TherapeuticsSeries B
- ChemoCentryxSeries D
- Ornim MedicalSeries C
- NeurogastrxSeries B
- GelesisSeries B
- Nabriva TherapeuticsSeries B
- AthenexPost-IPO Equity
- SientraSeries C
- Anthera PharmaceuticalsPost-IPO Equity
- Turning Point TherapeuticsPrivate Equity Round
- Magenta TherapeuticsPost-IPO Equity
- Vivimed LabsPost-IPO Equity
- MedigusPost-IPO Equity
- ForteBioSeries C
- Eddingpharm (Cayman)Series B
- AmarinPost-IPO Equity
- Cerimon PharmaceuticalsSeries A
- Manipal AcunovaVenture Round
- ReceptosVenture Round
- MID LabsVenture Round
- Shasun PharmaPrivate Equity Round
- Amnis CorporationSeries C
- RejuvenonSeries B
- MethylGeneVenture Round
- Avalon PharmaceuticalsSeries B
- Principia Biopharma
- SI-BONE
- Avanir Pharmaceuticals
Also in the portfolio
- Caris Life Sciences
- BioAge Labs
- Apogee Therapeutics
- Nautilus Biotechnology
- Carrot Fertility
- Nuvation Bio
- TigerConnect
- Crossover Health
- Natera
- CHARM Therapeutics
- Treeline Biosciences
- Tyra Biosciences
- Verdiva Bio
- Averna Therapeutics
- TandemAI
- Stairway Medical
- Evozyne
- Evox Therapeutics
- Health Catalyst
- Prelude Therapeutics
- EDDA Technology
- Clover Biopharmaceuticals
- Magenta Medical
- Nucleix
- Inspire Medical Systems
- TransMedics
- Aer Therapeutics
- Shattuck Labs
- Alector
- Ikena Oncology
- Affimed
- Acutus Medical
- Aduro BioTech
- Imara
- Arsanis
- Practice Fusion
- Roka Bioscience
- Cerexa Inc.
Investors similar to OrbiMed
RA Capital Management150 investments · 92 on the map · $6.7B raised
Foresite Capital50 investments · 13 on the map · $6.4B raised
Oxford Finance LLC51 investments · 11 on the map · $1.7B raised
Fidelity223 investments · 153 on the map · $17.4B raised
Armentum Partners56 investments · 14 on the map · $1.7B raised
HBM Healthcare Investments56 investments · 10 on the map · $3.4B raised